CVS, Cigna and Lina Khan
CVS, UnitedHealth, Cigna say FTC should take Lina Khan and two commissioners off drug middlemen case
The companies argue the commissioners have "a lengthy track record of making public statements that indicate serious bias" against pharmacy benefit managers.
CVS, UnitedHealth, Cigna Ask FTC's Khan to Disqualify Herself From Insulin Case
NEW YORK (Reuters) -CVS Health, UnitedHealth Group and Cigna have asked U.S. Federal Trade Commission chair Lina Khan and commissioners Rebecca Kelly Slaughter and Alvaro Bedoya to disqualify themselves from an FTC lawsuit that has accused the companies of unlawfully inflating insulin prices.
CVS, Cigna Seek to Disqualify FTC Officials in Insulin Case Over Alleged Bias
The healthcare company said Chair Lina Khan, Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro Bedoya through public statements show they have prejudged the matter at hand.
CVS, Cigna, UnitedHealth press for FTC Chair Khan to be removed from PBM lawsuit
Cigna, UnitedHealth and CVS Caremark are calling Federal Trade Commission (FTC) Chair Lina Khan and two other commissioners to either recuse themselves, or be removed from the agency’s lawsuit
CVS, UnitedHealth seek FTC recusal over bias in insulin case
The FTC has accused units of CVS, Cigna and UnitedHealth of unfair trade practices in how they managed insulin prescriptions.
Cigna seeks to disqualify FTC Chair Lina Khan from insulin case because of alleged bias
Cigna said that Khan, along with Commissioners Rebecca Kelly Slaughter and Alvaro Bedoya, have made repeated and incorrect prejudgments that show bias against pharmacy-benefit managers.
Healthcare Firms Call FTC’s Khan Biased. They Want Her Off the Insulin Case.
The agency has filed an administrative complaint accusing pharmacy benefit managers of artificially inflating the price of insulin.
CVS, UnitedHealth Request FTC Chair Recusal Amid Ongoing Pharmacy Benefit Managers Lawsuit
The FTC has filed a formal complaint accusing CVS, Cigna, and UnitedHealth of engaging in anti-competitive practices that ...
CVS is under pressure and considering a breakup. Here's why that could be risky.
CVS risks losing customers and revenue if it splits up its vertically integrated business segments, which includes health ...
CVS Health snaps six straight sessions of gains
Shares of CVS Health (NYSE:CVS) traded marginally lower on Friday after rising from a low of $62.92 from past six trading sessions, where shares grew overall 6% to a high of $66.63. Today’s the stock ...
Fortune21d
FTC Sues CVS, Cigna, UnitedHealth over insulin prices
The US Federal Trade Commission sued units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. on Friday, ...
Exclusive: CVS explores options including potential break-up, sources say
CVS Health is exploring options that could include a break-up of the company to separate its retail and insurance units, as ...
'Not going to sit back and do nothing': How CT officials are reacting to layoffs at CVS/Aetna
As CVS Health lays off more than 400 positions connected to its offices in Hartford, state officials have several initiatives ...
Are CVS Health, Cigna, and UnitedHealth Group Stocks Bad News Buys With the FTC's PBM Crackdown?
Unsurprisingly, CVS Health, Cigna, and UnitedHealth Group stocks fell last week after the FTC lawsuit announcement. But are these PBM stocks bad news buys?